Biggest quarter ahead from the company and peers after the pre clinical success and 8 years of development to this point are trading at 70-100 million market caps. 10 million market cap with 10 million in funding is a joke. The below tells you where this is going. Should be trading at a 60-70 cent share price leading into phase 2 but it’s coming
Ann: Significant Neuroprotection in NYR Preclinical Brain Injury, page-176
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
-0.002(3.39%) |
Mkt cap ! $10.38M | |||
| Open | High | Low | Value | Volume |
| 6.3¢ | 6.3¢ | 5.7¢ | $35.22K | 592.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 151330 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.1¢ | 163950 | 1 |
View Market Depth
| Last trade - 15.59pm 21/06/2024 (20 minute delay) ? |
| NYR (ASX) Chart |